Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission.
Wing-Yan
WY
Au
Seok-Jin
SJ
Kim
Harry H Y
HH
Yiu
Roger K C
RK
Ngan
Florence
F
Loong
Won-Seog
WS
Kim
Yok-Lam
YL
Kwong
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D055611:Natural Killer T-Cells / Q000473:pathology*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009669:Nose Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D012189:Retrospective Studies; D016879:Salvage Therapy; D017741:Survivors; D055815:Young Adult